ASX-listed MGC Pharmaceuticals has bolstered its European medicinal cannabis growing operations by shifting nearly 500 marijuana plants to the company’s facilities in the Czech Republic. MGC is moving full steam ahead with its botanical division, largely based in the EU, after last month receiving a full European licence to grow cannabis.
Related Data & Insights
-
-
Rank Company Revenue th Argent BioPharma $1.7m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX